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VariantIntratypic diversity of human papillomavirus (HPV) genome is generally characterized by point mutation,
insertion, and/or deletion. Using PCR-based cloning and sequencing, we detected concurrent infection with 8
HPV16 variants in a woman enrolled in the ASCUS-LSIL Triage Study. The European variant was the major
variant; each of the 7 minor variants had partial DNA sequences identical to the European variant and
another part identical to the African 2 variant. At a follow-up visit, only an HPV16 African 2 variant was
detected. Results from the present study suggest presence of intratypic recombination of HPV genome in
natural infection.
© 2009 Elsevier Inc. All rights reserved.Introduction
Papillomavirus is an extremely diversiﬁed group of viruses. To
date, more than 100 human papillomavirus (HPV) types have been
characterized (de Villiers et al., 2004). For any given type of HPV, viral
isolates that differ by less than 2% DNA sequence of the L1 open
reading frame are further classiﬁed as variants. The intratypic
diversity of HPV genome is generally documented as point mutation,
insertion, and/or deletion. Inter- or intratype recombination of HPV
genome, although presumed theoretically, has not yet been reported
from natural infections. By using phylogeny-based recombination
detection methods, Varsani et al. (2006) suggested a possibility of
exchange of HPV genes in a recombination model and delineated
potential recombinant descendants of the ancestral sequences. Recent
phylogenetic analyses further predicted intratypic recombination of
HPV16 genomewith potential breakpoints in the E7 gene (Angulo and
Carvajal-Rodriguez, 2007; Carvajal-Rodriguez, 2008).
HPV16 is the type that confers the highest risk of invasive cervical
cancer (Munoz et al., 2003). Investigations of diversity of HPV16
genome have identiﬁed 5 major phylogenetic lineages: European (E),
Asian, Asian-American, African 1, and African 2 (Af2) variants
(Eriksson et al., 1999; Yamada et al., 1997). Reported in this study
are recombinant sequences of HPV16 variants detected in a woman
who participated in the ASCUS-LSIL Triage Study (Schiffman and
Adrianza, 2000).PV Research Group, Northgate
ttle, WA 98125, USA. Fax: +1
ll rights reserved.Results
The study subject had HPV6, HPV16, HPV45, and HPV56 detected
in her enrollment sample; 20 months later she had a follow-up
sample positive for HPV16 alone. A polymerase chain reaction (PCR)-
based subcloning and sequencing of the 751-bp fragments of HPV16
genome (from nucleotide positions 7723 to 569) was performed on
both cervical swab samples. As shown in Table 1, the initial analysis of
10 clones from the enrollment sample revealed that 8 clones
contained sequences identical to HPV16 prototype (i.e., E variant); 1
clone had alterations of C-to-T, C-to-T, G-to-A, G-to-T, A-to-C, A-to-G,
and G-to-A at positions 7764, 7786, 7826, 7834, 7837, 7839, and 7868,
respectively; and another clone had alterations of C-to-T, A-to-T, T-to-
C, G-to-T, C-to-G, and G-to-T at positions 31, 90, 109, 132, 143, and
145, respectively. Although these alterations were the same as those
of HPV16 Af2 variant at the corresponding positions, the fragments in
the latter 2 clones were not derived from the Af2 variant because
sequences in the remaining part of the long control region and/or the
E6 region were identical to the E variant. Given that nucleotide
alterations across HPV genomes are often linked, the sequences with
apparent disconnection of the alterations suggest a recent break and
recombination. We therefore designated these 2 clones as HPV16
recombinants rather than new variants. Recombinant 1 had a
potential breakpoint between positions 7868 and 31 whereas
recombinant 2 had potential breakpoints between positions 7868
and 31 and between positions 145 and 286.
Considering that nucleotide alterations detected in a single clone
might result from PCR errors, the cervical sample was reassayed by
PCR-based cloning and sequencing. Again, the prototype sequences
were detected in 8 clones of the enrollment sample and recombinant
Table 1
DNA sequence variations of HPV16 variants from nucleotide positions 7722 to 567 detected by polymerase chain reaction-based cloning and sequencing.
Sample No. of
clones
Nucleotide alterations at positiona HPV16
prototype
7764 7786 7826 7834 7837 7839 7868 31 90 109 132 143 145 286 289 335 403
C C G G A A G C A T G C G T A C A
Initial test Enrollment 8 – – – – – – – – – – – – – – – – – E variant
Enrollment 1 T T A T C G A – – – – – – – – – – Recombinant 1
Enrollment 1 – – – – – – – T T C T G T – – – – Recombinant 2
Follow-up 10 T T A T C G A T T C T G T A G T G Af2 variant
Retest Enrollment 8 – – – – – – – – – – – – – – – – – E variant
Enrollment 1 T T A T C G A T T C T G T – – – – Recombinant 3
Enrollment 1 – – – – – – – – T C T G T A G T G Recombinant 4
Follow-up 10 T T A T C G A T T C T G T A G T G Af2 variant
a The nucleotide positions are numbered according to those documented in Human Papillomavirus 1997 Compendium (Meissner, 1997) and correspond to those of the original
HPV16 sequence (Seedorf et al., 1985). For each variant sequence, positions that are identical to the prototype sequence are marked with a dash in the alignment. HPV=human
papillomavirus; E=European; Af2=African 2.
9Rapid Communicationsequences were detected in 2 clones that were designated as HPV16
recombinants 3 and 4, respectively (Table 1). Although these
recombinants differed in positions of breakpoints, 7 out of 13
nucleotide alternations between recombinants 1 and 3 and 5 out of
10 nucleotide alternations between recombinants 2 and 4 overlapped.
An additional analysis of 85 clones from another PCR-based cloning of
enrollment sample revealed that 82 clones contained sequences
identical to the prototype; 1 had alterations of C-to-T at position 335
and A-to-G at position 403; 1 had alterations of T-to-A, A-to-G, C-to-T,
and A-to-G at positions 286, 289, 335, and 403, respectively; and the
third displayed sequences the same as recombinant 4 except for an
additional change of C-to-T at position 31. Sequences of 20 clones
from the follow-up sample (10 from the initial test and 10 from the
repeat) were identical to sequences of HPV16 Af2 variant.
To examine whether these recombinant sequences resulted from
artifacts of PCR- or cloning-mediated recombination, we designed a
recombinant-speciﬁc PCR (RS-PCR) according to the known
sequences. The speciﬁcity of the assay was conﬁrmed by testing a
group of plasmids. As shown in Fig. 1, plasmid samples with HPV16
recombinant 1 or 3 were positive by RS-PCR with primer set A; those
with HPV16 recombinant 2 or 4 were positive by RS-PCR with primer
set B; and those with HPV16 E or Af2 variant were negative by RS-PCR
with either primer set A or primer set B. The PCR products of the
enrollment sample were positive by RS-PCR with either set of primers
(lane 7). This suggests that these recombinant sequences were
present prior to the cloning procedure. When the RS-PCR wasFig. 1. Products of recombinant-speciﬁc polymerase chain reaction (RSP) with primer
sets A (upper part) or B (lower part) on 1.5% ethidium bromide-stained agarose gel.
Lane M, 100-bp DNA marker; lanes 1–6, plasmids with human papillomavirus type 16
European variant, African 2 variant, recombinants 1, 2, 3, and 4, respectively; lane 7, PCR
products of enrollment sample; lane 8, PCR products of follow-up sample; lane 9,
enrollment sample; and lane 10, follow-up sample; lane N, no DNA template control.performed on the enrollment sample, only the one with primer set
B displayed a visible band (lane 9), suggesting presence of the
recombinant sequences in natural infection.
One concern was whether the positive bands generated by RS-PCR
resulted from potential plasmid contamination. To address this, the
cervical sample and its PCR products were assayed by PCR with M13
forward and reverse primers. This set of primers is able to amplify
sequences of the vector we used. No positive signal was seen on the
agarose gel (data not shown). A direct DNA sequencing of the RS-PCR
products revealed that sequences generated with primer set A were
identical to HPV16 recombinant 1 and those with primer set B were
identical to the recombinant 4. Neither the follow-up sample (lane
10) nor its PCR product (lane 8) was positive by RS-PCR. To determine
whether we were able to detect the Af2 variant from the enrollment
sample and the E variant from the follow-up sample, both samples
and their 751-bp PCR products were PCR assayed with a pair of
primers for the E variant (forward primer B and reverse primer A) and
a pair of primers for Af2 variant (forward primer A and reverse primer
B). Consistent with the sequencing results, the enrollment sample and
its PCR products were positive by PCRwith the ﬁrst but not the second
set of primers, vice versa for the follow-up sample and its PCR
products (data not shown).
In view of a change of the predominant variants between the
enrollment and follow-up visits, another concern was whether there
was a sample switch or sample-to-sample contamination. To address
this, both samples were tested for polymorphisms of short tandem
repeats (STRs) by PCR-based combined DNA index system. The
genotypic proﬁle is summarized in Table 2. We initially tested 2
diluted samples (0.1 ng/μl) in triplicate. All 3 replicates of diluted
follow-up sample were allele matched exactly. All replicates of
diluted enrollment sample were also consistent except for locus vWA
of replicate 2. The enrollment sample was reassayed in undiluted
form (1 ng/μl). The patterns were exactly the same as those seen in
the follow-up sample. Since the inconsistency was restricted to a
single locus on 1 out of the 4 replicates (3 diluted and 1 undiluted),
it is deemed insigniﬁcant. Because the probability of 2 different
samples matching by chance for polymorphisms of all 9 STRs is only
1.36×10-12 (Sacchetti et al., 1999), both samples should be from the
same person.
Discussion
In efforts to examine the genomic diversity of HPV16 variants, we
found recombinant sequences of the E and Af2 variants in 1 specimen.
These sequences, although detected only in a single clone, were
unlikely due to PCR errors because all of the nucleotide alterations
matched to the Af2 variant at the corresponding positions and the
majority of them were overlapped between the clones. Also, it is
unlikely that the result was an artifact of cloning-mediated
Table 3
Primers for recombinant-speciﬁc polymerase chain reaction.
Sequencea (5′–3′) Nucleotide position
Primer set A
Forward A TAGTCATACATTaTTCATTTtTAcAg 7814–7839
Reverse A TTCCATACAAACTATAACAATAATG 335–359
Primer set B
Forward B TAGTCATACATTGTTCATTTGTAAAA 7814–7839
Reverse B TTGTTTGCAGCTCTGTGCATAAa 145–167
Primer sets A and B were designed to target recombinants 1 and 3 and recombinants
2 and 4, respectively.
a Italicized letters indicate positions where the nucleotides differ between the
HPV16 prototype and the Af2 variant: capital letters, identical to the prototype; small
letters, identical to the Af2 variant.
Table 2
Proﬁling of short tandem repeats in 9 loci and amelogenin.
D35S1358 vWA FGA Amelogenin D8S1179 D21S11 D18S51 D5S818 D13S317 D7S820
Follow-up sample Replicate 1 15 16 15 18 26 X 14 15 28 32.2 14 16 11 14 12 13 10 11
Replicate 2 15 16 15 18 26 X 14 15 28 32.2 14 16 11 14 12 13 10 11
Replicate 3 15 16 15 18 26 X 14 15 28 32.2 14 16 11 14 12 13 10 11
Enrollment sample Replicate 1 15 16 15 18 26 X 14 15 28 32.2 14 16 11 14 12 13 10 11
Replicate 2 15 16 12 15 18 26 X 14 15 28 32.2 14 16 11 14 12 13 10 11
Replicate 3 Insufa 15 15 18 26 X 14 15 28 32.2 14 16 11 14 12 13 10 11
Undiluted 15 16 15 18 26 X 14 15 28 32.2 14 16 11 14 12 13 10 11
a Insufﬁcient for evaluation because it had a call that fell out of the bin.
10 Rapid Communicationrecombination because the recombinant sequences were detected
from the PCR products prior to the cloning procedure.We are aware of
a possibility of potential PCR-mediated recombinationwhich can arise
due to presence of multiple related sequence templates, incomplete
primer extension, and crossover events in the PCR cycle (Judo, Wedel,
and Wilson, 1998; Shaﬁkhani, 2002; Wu et al., 2007). However, there
was no detectable Af2 variant template in this specimen. More
importantly, the recombinant sequences were detected directly from
the cervical sample by RS-PCR with primer set B.
These recombinant sequences differed in number of copies. As
suggested by direct DNA sequencing of the RS-PCR products,
recombinants 1 and 4 were more abundant than recombinants 3
and 2, respectively. The copy number of recombinant 4 was larger
than that of recombinant 1 because only the former was detected by
RS-PCR of the enrollment sample. The presence of multiple recombi-
nants in a single sample is not totally unexpected, given that parental
sequences can be disrupted at different sites. It is possible that more
recombinants might have been found, had a whole genome been
examined.
It should be pointed out that recombination after diversiﬁcation of
HPV16 variants might be a rare event because it has not been reported
before. In this study, it was detected only in 1 of 80 samples analyzed.
We do not know how these recombinant sequences were formed. If
the recombinants result from a recent homologous recombination, a
concurrent presence of both E and Af2 variants is required. However,
no Af2 variant was detected from this sample, even by PCR with a set
of primers speciﬁc for Af2 variant. It is unclear whether the Af2 variant
was latent at the time of sample collection. Alternatively, the study
subject might have acquired different HPV16 recombinants concur-
rently or separately from the same or different sex partners.
Neither HPV16 prototype nor recombinant was detected, but Af2
variant was in the follow-up sample. It remains unanswered whether
the disappearance of the prototype and recombinants at a follow-up
visit was due to a clearance of the infection or suppression to a level
below the detectable threshold. One may think that the recombinant
sequences might be intermediates of the change from the prototype
to Af2 variant. However, this does not seem biologically plausible
because of a slow evolutionary process of HPV (Bernard, Chan, and
Delius, 1994), More likely, the Af2 variant detected in the follow-up
sample represented reactivation of a latent infection or a separate
infection. Given that HPV16 variants that are abundant initially
usually remain predominant at subsequent visits (van Belkum et al.,
1995; Xi et al., 1995), a change of the predominant variants found in
this study was a rare event. The reason for this is not clear.
To the best of our knowledge, this is the ﬁrst report showing
HPV16 recombinant sequences in natural infection. Our data suggest
that similar to other viruses (Nimonkar and Boehmer, 2003; Thiry et
al., 2005), DNA recombination might play a role in diversiﬁcation of
HPV genome. It may occur after diversiﬁcation of HPV variants and
continue to drive the evolution of current HPV types and variants. This
may in part explain extraordinary diversity of this family of viruses.
In summary, the present study provided evidence of HPV16
recombinant sequences in natural infection but no evidence of
sustained replication of these recombinants.Materials and methods
Specimen
Cervical swab samples in Specimen Transport Medium (Digene
Corporation, Silver Spring, MD) were from women enrolled in the
ASCUS-LSIL Triage Study. Of 40 pairs of HPV16-positive enrollment
and follow-up samples analyzed, only one displayed recombinant
sequences of HPV16 variants. This pair of samples was collected from
a 21-year-old woman on May 27, 1997 (enrollment), and January 28,
1999 (follow-up), respectively.
PCR-based cloning and sequencing
The 751-bp DNA fragments (corresponding to the 3′ part of HPV16
long control region and the entire E6 region) were generated by PCR
with a pair of primers (forward, nucleotide positions 7701–7722, 5′-
AGGCACATATTTTTGGCTTGTT; reverse, nucleotide positions 591–568,
5′-TTCATGCAATGTAGGTGTATCTCC). PCR products were cloned into
plasmids using a TOPO TA Cloning kit according to the protocol
recommended by the manufacturer (Invitrogen, Carlsbad, CA). Clones
containing target inserts were identiﬁed by digestion with appropri-
ate restriction enzymes followed by electrophoreses on 1.5% agarose
gel. Plasmid DNAs were puriﬁed with a QIAprep Spin Miniprep Kit
(Qiagen, Valencia, CA). The puriﬁed DNA templates were sequenced
by Northwoods (Northwoods DNA Inc., Solway, MN). To minimize
PCR error-introduced misclassiﬁcation, DNA fragments for cloning
were generated by 2 independent PCR assays and 20 clones per
sample were selected for sequencing. To verify the recombinant
sequences, another PCR-based cloning was performed on the
enrollment sample and additional 85 clones were sequenced. DNA
sequences were analyzed using Sequencer™ software (Gene Codes
Corp., Ann Arbor, MI).
Recombinant-speciﬁc PCR
The RS-PCR was used to examine whether the recombinant
sequences were PCR- or cloning-related artifacts. The internal
primers listed in Table 3 were designed to speciﬁcally bind to the
11Rapid Communicationknown recombinant sequences. If the nucleotide at the 3′ end of
the forward primer is identical to the E variant, the nucleotide at
the 3′ end of the reverse primer is identical to the Af2 variant,
and vice versa. The speciﬁcity of the RS-PCR was assessed by
testing a set of plasmid samples with known inserted sequences.
An aliquot of 2 μl PCR products or cervical sample DNA extracts
was assayed by RS-PCR in a reaction volume of 25 μl containing
1×PCR buffer, 3 mM MgCl2, 200 mM dNTP, 10 mM primers, and
1.25 U AmpliTag Gold™ (Roche Molecular Systems, Branchburg,
NJ). Ampliﬁcation was carried out with a cycling program of 30 s
at 95 °C, 1 min at 58 °C, and 1 min at 72 °C for 35 cycles. The
RS-PCR products were visualized on 1.5% ethidium bromide-
stained agarose gel and veriﬁed by direct DNA sequencing. To
determine whether there was an Af2 variant in the enrollment
sample and an E variant in the follow-up sample, we further
paired these internal primers differently to make them speciﬁcally
target the Af2 or E variant.Authentication of sample identity by PCR-based combined DNA index
system
To determine whether the enrollment and follow-up samples
were from a same person, DNA fragments of STRs necessary for
combined DNA index system typing in 9 loci (Sacchetti et al., 1999)
and Amelogenin on the sex chromosomes (Mannucci et al., 1994)
were PCR generated using the AmpFLSTR Proﬁler Plus kit (Applied
Biosystems, Foster City, CA). Allele assignment was done by
Genemapper software (Applied Biosystems) based on AmpFLSTR
program parameters. The software also assigns the peak number
labels in accordance with an AmpFLSTR-provided ladder to indicate
the number of STRs at the loci. Two samples are identical if all alleles
match across loci.Acknowledgments
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